0001905880-22-000001.txt : 20220225 0001905880-22-000001.hdr.sgml : 20220225 20220225164629 ACCESSION NUMBER: 0001905880-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220225 DATE AS OF CHANGE: 20220225 EFFECTIVENESS DATE: 20220225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reset Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001905880 IRS NUMBER: 851188833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-435097 FILM NUMBER: 22681170 BUSINESS ADDRESS: STREET 1: 241 CENTRAL PARK W APT 9A CITY: NEW YORK STATE: NY ZIP: 10024 BUSINESS PHONE: 646-342-2583 MAIL ADDRESS: STREET 1: 241 CENTRAL PARK W APT 9A CITY: NEW YORK STATE: NY ZIP: 10024 D 1 primary_doc.xml X0708 D LIVE 0001905880 Reset Pharmaceuticals, Inc. 241 CENTRAL PARK W APT 9A NEW YORK NY NEW YORK 10024 646-342-2583 DELAWARE None None Corporation true 2020 Jan-Anders Karlsson 241 Central Park W Apt 9A New York NY NEW YORK 10024 Executive Officer Director John Andreadis 241 Central Park W Apt 9A New York NY NEW YORK 10024 Executive Officer Director Philip Taub 241 Central Park W Apt 9A New York NY NEW YORK 10024 Director Tim Schlidt 241 Central Park W Apt 9A New York NY NEW YORK 10024 Director Pharmaceuticals Decline to Disclose 06b false 2021-11-26 false true false 25000 12714610 11115105 1599505 false 26 0 0 0 false Reset Pharmaceuticals, Inc. /s/ Jan-Anders Karlsson Jan-Anders Karlsson President and CEO 2022-02-16